Sudarshan Pharma, a leading pharmaceutical company in India, recently announced the launch of its Initial Public Offering (IPO). This is a major milestone for the company and marks the first time it has offered its shares to the public. Investors are eager to learn more about the IPO subscription availability and timeline.
The IPO subscription period is expected to begin on April 15th and will run until April 19th. During this period, investors can purchase shares of Sudarshan Pharma at a fixed price. The company has set the price of each share at Rs. 250. The minimum investment amount is Rs. 10,000, and investors can purchase up to a maximum of 4,000 shares.
In order to participate in the IPO, investors must open a demat account with a registered broker or depository participant. They must also complete the application form and submit it to the broker or depository participant. Once the application is approved, investors will be able to purchase shares of Sudarshan Pharma during the subscription period.
The IPO is being managed by Axis Capital, ICICI Securities, and JM Financial. These firms are responsible for collecting applications and distributing shares. They will also provide investors with updates on the status of their applications.
Sudarshan Pharma is a leading pharmaceutical company in India with a strong presence in the domestic market. The company has a wide range of products including generic drugs, over-the-counter medicines, and specialty drugs. The company has also established a strong presence in the international market with its exports to more than 50 countries.
The IPO is an important milestone for Sudarshan Pharma as it marks its entry into the public markets. Investors who participate in the IPO will be able to benefit from the long-term growth potential of the company. Those who are interested in participating in the IPO should make sure to review all the details before making their investment decision.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: Plato Data Intelligence: PlatoAiStream
